{"version":"1.0","type":"link","title":"A concept for a new approach to combined oral contraception from adolescence to perimenopause: Continuous use of the oral GnRH antagonist Relugolix and the fetal estrogen Estetrol.","author_name":"Coelingh Bennink HJT 외","author_url":"https://prs-insight.online/author/Coelingh%20Bennink%20HJT","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/78398","thumbnail_width":1200,"thumbnail_height":630}